20/20 Closes Record Equity Crowdfunding Campaign

20/20 Closes Record Equity Crowdfunding Campaign

20/20 GeneSystems, Inc. finalized its first equity crowdfunding campaign this week with gross proceeds of $1.07 million, the maximum amount permitted under current SEC rules pursuant to Regulation CF. In so doing, the company became only the second medical technology...

Ping An Ventures Takes Equity Stake in 20/20 GeneSystems

Investment to Accelerate Commercialization of Lung Cancer Test in China The funds will support 20/20’s efforts to customize for the Chinese market its proprietary algorithm for blood biomarker testing for cancer. The algorithm will then be made available to...